Dr Caleb O Gaston, MD | |
5206 Village Pkwy Ste 10, Rogers, AR 72758-8137 | |
(479) 657-6600 | |
(479) 657-6632 |
Full Name | Dr Caleb O Gaston |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 24 Years |
Location | 5206 Village Pkwy Ste 10, Rogers, Arkansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164496105 | NPI | - | NPPES |
148082001 | Medicaid | AR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | E-3376 (Arkansas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mercy Hospital Northwest Arkansas | Rogers, AR | Hospital |
Northwest Medical Center-springdale | Springdale, AR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Apex Family Medical Clinic, Pa | 3577717925 | 4 |
News Archive
Researchers from the Department of Chemistry and Molecular Biology at the University of Gothenburg have managed for the first time to obtain detailed information about the role of the protein metastasin in the spread of tumour cells.
A study conducted in Denmark showed that 86% of Rebif®-treated patients found that injections were easier and less painful using the new needle. The pre-filled syringe of Rebif® with the new needle is available in the same dosages as the previous version and will continue to carry the same indication. It is currently being launched in Europe and will be available worldwide by the end of 2004.
Alexza Pharmaceuticals, Inc. announced today that it has resubmitted its ADASUVE New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter (CRL) received in May 2012.
POZEN Inc. (NASDAQ:POZN), today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for VIMOVO™ (enteric-coated naproxen / immediate release esomeprazole magnesium, formerly know as PN 400).
› Verified 2 days ago
Entity Name | Apex Family Medical Clinic, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437409109 PECOS PAC ID: 3577717925 Enrollment ID: O20130212000191 |
News Archive
Researchers from the Department of Chemistry and Molecular Biology at the University of Gothenburg have managed for the first time to obtain detailed information about the role of the protein metastasin in the spread of tumour cells.
A study conducted in Denmark showed that 86% of Rebif®-treated patients found that injections were easier and less painful using the new needle. The pre-filled syringe of Rebif® with the new needle is available in the same dosages as the previous version and will continue to carry the same indication. It is currently being launched in Europe and will be available worldwide by the end of 2004.
Alexza Pharmaceuticals, Inc. announced today that it has resubmitted its ADASUVE New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter (CRL) received in May 2012.
POZEN Inc. (NASDAQ:POZN), today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for VIMOVO™ (enteric-coated naproxen / immediate release esomeprazole magnesium, formerly know as PN 400).
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Caleb O Gaston, MD 5206 Village Pkwy Ste 10, Rogers, AR 72758-8137 Ph: (479) 657-6600 | Dr Caleb O Gaston, MD 5206 Village Pkwy Ste 10, Rogers, AR 72758-8137 Ph: (479) 657-6600 |
News Archive
Researchers from the Department of Chemistry and Molecular Biology at the University of Gothenburg have managed for the first time to obtain detailed information about the role of the protein metastasin in the spread of tumour cells.
A study conducted in Denmark showed that 86% of Rebif®-treated patients found that injections were easier and less painful using the new needle. The pre-filled syringe of Rebif® with the new needle is available in the same dosages as the previous version and will continue to carry the same indication. It is currently being launched in Europe and will be available worldwide by the end of 2004.
Alexza Pharmaceuticals, Inc. announced today that it has resubmitted its ADASUVE New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter (CRL) received in May 2012.
POZEN Inc. (NASDAQ:POZN), today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for VIMOVO™ (enteric-coated naproxen / immediate release esomeprazole magnesium, formerly know as PN 400).
› Verified 2 days ago
Anthony Meloy, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4305 S Pleasant Crossing Blvd Ste 3, Rogers, AR 72758 Phone: 479-289-8376 | |
Dr. John Newland Redwine, DO, FAAFP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 24 Bracebridge Rd, Rogers, AR 72756 Phone: 479-871-1981 | |
Dr. Dustin Paul Pope, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5206 W Village Pkwy Ste 10, Rogers, AR 72758 Phone: 479-657-6600 Fax: 479-657-6632 | |
Dr. Andrew White, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2710 S Rife Medical Ln, Rogers, AR 72758 Phone: 479-338-8000 | |
Shelby Wigginton, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2708 S Rife Medical Ln Ste 130, Rogers, AR 72758 Phone: 479-338-5555 Fax: 479-338-5533 | |
Dr. Amanda Marie Ferguson Wood, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2708 S Rife Medical Ln, Rogers, AR 72758 Phone: 479-338-5555 Fax: 479-338-5533 | |
Martin A Hannon, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3730 S Pinnacle Hills Pkwy Ste 2, Rogers, AR 72758 Phone: 479-464-5599 Fax: 479-464-5598 |